innerbuddies gut microbiome testing

Gut Microbiome During Pregnancy: Maternal Health and Infant Gut & Immune Development

Your baby’s health begins long before birth—and a key player is the maternal gut microbiome. During pregnancy, trillions of microbes in the mother’s intestines help shape the metabolic and immune signals that influence how the infant gut develops, how the immune system “learns,” and how the body responds to inflammation and infection after delivery.

The maternal microbiome can also affect the microbial exposures an infant receives at birth and during early life. Through immune pathways and microbial metabolites (such as short-chain fatty acids) carried through the maternal circulation, gut microbes help modulate cytokine patterns, support gut barrier function, and create an internal environment that may promote a more balanced infant gut ecosystem. These early microbial communities are strongly linked to digestion, stool patterns, resistance to dysbiosis, and the programming of immune tolerance.

Because the microbiome responds to daily inputs, maternal health factors—dietary fiber and overall nutrition, body weight and metabolic health, stress and sleep, antibiotic or medication exposure, and even mode of delivery planning—can shift the microbial balance in ways that matter for the developing fetus. By understanding what supports a diverse, resilient maternal gut microbiome, you can better appreciate why gut health during pregnancy may contribute to long-term infant wellness.

Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Maternal microbiome / infant health

Pregnancy reshapes the maternal gut microbiome through hormonal shifts, metabolic changes, altered gut motility, and immune modulation. This upstream ecosystem influences intestinal barrier integrity and immune signaling, largely via metabolites like short-chain fatty acids that help regulate inflammation. Maternal factors such as diet quality and fiber intake, metabolic health, gestational weight gain, antibiotic exposure, stress, sleep, and mode of delivery shape which microbes thrive and what they produce, ultimately impacting how the infant’s gut and immune system develop after birth.

  • SCFA-producing taxa Faecalibacterium prausnitzii, Roseburia spp., and Eubacterium rectale generate butyrate and other short-chain fatty acids that strengthen the maternal gut barrier and promote tolerogenic immune signaling, shaping infant gut colonization and immune maturation.
  • Bifidobacterium longum subsp. infantis is pivotal for early infant gut seeding and immune education; higher maternal abundance can influence initial infant microbiome trajectories.
  • Akkermansia muciniphila supports mucin layer integrity and intestinal barrier function, contributing to a healthier metabolic-immune environment for infant colonization.
  • Bacteroides fragilis and Bacteroides uniformis provide immune-modulatory signals and effective polysaccharide utilization, supporting balanced maternal-to-infant immune cues.
  • Ruminococcus bromii drives resistant starch fermentation and robust SCFA production, shaping the metabolite landscape that aids gut barrier maturation and immune calibration.
  • Dietary fiber-rich patterns and limited antibiotic exposure during pregnancy help preserve these beneficial taxa and their metabolic outputs, supporting maternal gut health and favorable infant microbiome seeding.
Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Pregnancy-related

The gut microbiome during pregnancy refers to the diverse community of microorganisms living in a pregnant person’s intestines. Pregnancy itself reshapes these microbial communities through hormonal shifts, changes in metabolism, altered gut motility, and immune system modulation. Because the maternal gut ecosystem interacts with intestinal barrier function and maternal immune signaling, it plays an important “upstream” role in setting the stage for how the infant’s gut microbiome and immune system develop after birth.

Maternal factors that can influence microbiome composition and function include diet quality and fiber intake, overall metabolic health (such as insulin sensitivity), body weight and gestational weight gain, antibiotic exposure, stress, sleep patterns, mode of delivery, and—often indirectly—genetic background and household environment. These influences matter because maternal microbes and their metabolic outputs (such as short-chain fatty acids) help regulate inflammation, support gut barrier integrity, and guide immune maturation. Emerging research also suggests that microbial metabolites and immune cues may reach the maternal–fetal interface, while early-life exposures (including breastfeeding and contact with the mother’s microbiome) further determine which microbes successfully colonize the infant gut.

Why this matters for long-term wellness is that early microbial colonization is linked with immune development, including how the body trains its tolerance to harmless antigens and calibrates inflammatory responses. Associations have been reported between early microbiome patterns and future risks such as allergic disease, some inflammatory conditions, and metabolic outcomes, though results vary by study design and population. Supporting a healthier maternal gut microbiome during pregnancy—especially through adequate fiber-rich nutrition, minimizing unnecessary antibiotics, and promoting metabolic and stress-supportive habits—may help foster conditions that support infant gut colonization and immune development.

  • Bloating and irregular bowel movements (constipation or diarrhea)
  • Frequent gastrointestinal discomfort or abdominal pain
  • Frequent constipation or straining with incomplete evacuation
  • Signs of nutrient malabsorption (e.g., fatigue, unintended weight changes)
  • Recurrent vaginal infections or abnormal discharge (associated with microbiome imbalance)
  • Increased frequency of antibiotic use or recurrent infections during pregnancy
Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Maternal microbiome / infant health

Maternal microbiome / infant health is relevant for pregnant people who want to support both their own digestive well-being and their baby’s early immune and gut colonization. It can be especially meaningful if you notice gut changes during pregnancy—such as bloating, constipation or diarrhea, or frequent abdominal discomfort—because pregnancy hormones and immune shifts can alter gut microbial balance and gut barrier function.

It’s also relevant for those who have risk factors that may disrupt the maternal gut ecosystem, including lower dietary fiber intake, metabolic concerns (like reduced insulin sensitivity), significant gestational weight gain, higher stress or poor sleep, or repeated antibiotic exposure during pregnancy. These factors can influence microbial diversity and the production of helpful metabolites (like short-chain fatty acids) that support inflammation control and barrier integrity, which may indirectly affect how the infant’s gut microbiome develops after birth.

Consider it particularly relevant if you’re experiencing recurrent gastrointestinal symptoms, possible nutrient absorption issues (such as unusual fatigue or unintended weight changes), or repeated vaginal infections/abnormal discharge that may reflect broader microbiome imbalance. It may also be a useful focus if you’re planning for long-term wellness and want to understand how pregnancy-era microbial patterns, feeding practices (including breastfeeding), and mother–infant microbial transfer can shape the baby’s immune maturation and future health risk—potentially including allergy and metabolic outcomes.

Maternal gut microbiome changes are extremely common during pregnancy: longitudinal studies using 16S rRNA and metagenomic profiling consistently show that pregnancy is associated with measurable shifts in gut microbial composition and function across all major taxonomic groups and metabolic pathways. Reported microbial diversity often changes during gestation (with trends varying by trimester, cohort, and sequencing/analysis methods), indicating that the gut microbiome “during pregnancy” is a near-universal biological state rather than a rare condition.

While there isn’t a single, universally accepted prevalence rate for “maternal microbiome imbalance” (because microbiome patterns vary by diet, genetics, geography, and measurement methods), gastrointestinal symptoms that may accompany gut ecosystem disruption are common. Globally, constipation affects roughly 11–17% of pregnant people, while other reviews report pregnancy-related diarrhea/looser stools in a meaningful minority of cases; collectively, many studies find that a large fraction of pregnant individuals report bowel habit changes such as bloating, irregularity, constipation with straining, or abdominal discomfort.

Factors that strongly influence maternal microbiome composition—dietary fiber intake, antibiotic exposure, metabolic health (e.g., insulin resistance), gestational weight gain, stress and sleep disruption—also occur frequently and therefore indirectly contribute to widespread microbiome variability. Antibiotic use during pregnancy is also common in many settings (with studies often reporting several percent up to ~30% of pregnancies exposed, depending on region and indication), and recurrent infections or gastrointestinal complaints are frequently documented. Because early-life infant gut colonization depends partly on maternal microbial signals and metabolites, this high baseline prevalence of pregnancy-associated gut microbial shifts and common GI symptom patterns means a large proportion of pregnancies are likely to experience microbiome-altering conditions—even when symptoms are mild or intermittent.

Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Gut Microbiome During Pregnancy: How Maternal Health Shapes Infant Gut and Immune Development

Pregnancy reshapes the maternal gut microbiome through hormonal changes, shifts in metabolism, altered gut motility, and immune modulation. These microbial communities influence the integrity of the intestinal barrier and the balance of immune signaling, largely by producing metabolites such as short-chain fatty acids that help regulate inflammation. As a result, the maternal microbiome acts as an “upstream” factor that can shape the conditions the infant will experience during and after birth.

Maternal behaviors and exposures strongly affect microbial composition and function, including diet quality and fiber intake, metabolic health, gestational weight gain, sleep and stress, and antibiotic use. When diet is low in fiber or when antibiotics are used repeatedly, microbial diversity can decline and beneficial metabolite production may change—potentially affecting gut barrier function and immune calibration. Gut and vaginal ecosystem disruptions can also be related, since microbial imbalance during pregnancy may coincide with gastrointestinal symptoms (like bloating, constipation, or diarrhea) and sometimes recurrent vaginal infections or abnormal discharge.

Why this matters for long-term wellness is that early-life microbial colonization is closely tied to immune development and tolerance. The infant’s initial microbiome is influenced by the maternal gut (and broader maternal microbiome exposures), which may impact how the immune system trains to handle harmless antigens and controls inflammatory responses. Research has linked certain early microbial patterns with later risks such as allergic disease, some inflammatory conditions, and metabolic outcomes—supporting the idea that healthier maternal gut ecology during pregnancy may help promote more favorable infant gut colonization and immune maturation.

Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Gut Microbiome and Maternal microbiome / infant health

  • Hormone- and metabolism-driven reshaping of the maternal gut microbiome: Pregnancy hormones alter microbial growth conditions and host metabolism, shifting community composition and functional pathways that generate immunoregulatory metabolites for the fetus and newborn.
  • Immune modulation via microbial metabolites (especially short-chain fatty acids): Maternal microbes produce SCFAs (e.g., acetate, propionate, butyrate) that support intestinal barrier function and tune immune signaling (promoting tolerance and regulating inflammation), influencing infant immune calibration.
  • Intestinal barrier integrity and microbial translocation control: A healthier maternal microbial ecosystem helps strengthen tight junctions and mucus layers, reducing inflammatory signals from endotoxins/immune-activating components that can affect fetal and neonatal immune development.
  • Maternal-to-infant microbial seeding during pregnancy, birth, and early life: Maternal gut communities (and related metabolites) can contribute to the initial microbial exposure landscape that shapes the infant’s early gut colonization and downstream immune programming.
  • Behavior- and exposure-mediated dysbiosis (diet fiber, antibiotics, metabolic health): Low-fiber diets and repeated antibiotic use can reduce diversity and beneficial metabolite output, weakening barrier/immune signaling and altering the microbial trajectory the infant inherits.
  • Gut motility and enterohepatic signaling changes affecting microbial function: Pregnancy-associated changes in motility and bile acids can shift microbial fermentation and metabolite profiles, which in turn influence inflammatory tone and immune maturation relevant to the infant.
  • Linking gastrointestinal and vaginal ecosystem disturbances to immune outcomes: Gut dysbiosis during pregnancy can co-occur with vaginal dysbiosis, promoting broader dysregulated immune signaling and potentially affecting infant immune risk via shared inflammatory pathways.

Pregnancy reshapes the maternal gut microbiome through hormone-driven changes in the intestinal environment, shifts in host metabolism, and altered gut motility. These changes affect which microbes thrive and what they do—especially the production of metabolites that help regulate inflammation. As a result, the maternal gut can act as an “upstream” signal system that influences the conditions to which the fetus and newborn are exposed during pregnancy and early infancy, with downstream effects on gut barrier maturation and immune development.

A key pathway involves microbial metabolites, particularly short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs support the integrity of the intestinal barrier by nourishing epithelial cells and reinforcing tight junction function, while also tuning immune signaling toward tolerance and away from excessive inflammation. When the maternal gut ecosystem is healthier, metabolite output and barrier-supporting signals are more likely to be maintained, helping calibrate how the infant’s immune system responds to harmless antigens. In contrast, reduced diversity or altered fermentation (for example, after repeated antibiotic use or low-fiber intake) can weaken barrier function and shift immune-regulatory signaling.

Maternal microbes may also contribute directly and indirectly to the infant’s initial microbial “seeding” during pregnancy, birth, and early life. Pregnancy-associated changes in gut function (including bile acid and motility shifts) can modify which microbial functions are active, shaping the metabolite landscape the infant encounters. In parallel, gut dysbiosis during pregnancy can co-occur with vaginal ecosystem disturbances, promoting broader inflammatory tone through shared immune pathways. Together, these processes can influence how the infant’s early gut colonization trajectory trains immune tolerance and affects longer-term risks related to allergy, inflammatory conditions, and metabolic health.

Test Your Gut Microbiome Start Your Gut Microbiome Subscription
innerbuddies gut microbiome testing

Microbial patterns summary

During pregnancy, the maternal gut microbiome commonly shifts in composition and metabolic function in ways that reflect changes in hormones, diet, gut motility, and immune activity. Health-associated patterns typically include greater microbial diversity and a functional profile enriched for fermentation of dietary fibers, which supports the production of short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. These SCFAs are linked with stronger intestinal barrier integrity and more balanced immune signaling, helping maintain a lower inflammatory tone that can influence the microbial and immune “set point” the infant encounters during gestation and early life.

Maternal behaviors and exposures often shape whether these beneficial metabolic outputs are sustained. Diet patterns low in fiber, reduced microbial diversity, or repeated antibiotic exposure are frequently associated with diminished SCFA-generating capacity and an altered microbial ecosystem, which can compromise tight junction function and shift immune calibration toward a more reactive state. In this context, microbial patterns that show reduced fermentative taxa activity and altered gut metabolite production may correlate with gastrointestinal symptoms and a broader dysregulated immune environment—conditions that can plausibly affect early-life gut colonization trajectories and immune tolerance development.

Gut–vagina ecosystem connections during pregnancy can further reinforce these downstream effects. When maternal gut dysbiosis co-occurs with vaginal ecosystem disruption, shared immunologic pathways and inflammatory mediators may contribute to an elevated baseline inflammatory tone, which can influence the infant’s early microbial seeding and immune training. In contrast, maternal patterns that support gut barrier maintenance and stable SCFA output are thought to promote a more favorable microbial metabolite landscape during pregnancy and early infancy, supporting smoother colonization dynamics and potentially lowering later risk for allergic and inflammatory outcomes as the immune system matures.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Eubacterium rectale (Eubacterium hallii group)
  • Ruminococcus bromii
  • Bifidobacterium longum subsp. infantis
  • Bacteroides uniformis
  • Bacteroides fragilis (enterotype-associated strains with beneficial polysaccharide utilization)
  • Akkermansia muciniphila


Elevated / overrepresented taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Akkermansia muciniphila
  • Bifidobacterium longum subsp. infantis
  • Eubacterium rectale (Eubacterium hallii group)
  • Ruminococcus bromii
  • Bacteroides uniformis
  • Bacteroides fragilis (beneficial polysaccharide-utilizing strains)


Functional pathways involved

  • Dietary fiber fermentation and short-chain fatty acid (SCFA) production (acetate, propionate, butyrate) via acetate-propionate-butyrate metabolic networks
  • Butyrate biosynthesis pathways (e.g., from glycolysis/pyruvate and acetyl-CoA routes) that support colonic epithelial energy supply and barrier integrity
  • Biosynthesis and utilization of SCFA transporters and regulatory signaling that mediate epithelial tight-junction maintenance
  • Folate and other B-vitamin biosynthesis that supports maternal gut metabolic health and indirectly influences immune development
  • Bile acid metabolism (primary-to-secondary transformation and bile acid deconjugation) shaping antimicrobial properties, microbial fitness, and host immune tone
  • Mucin/glycan degradation and mucosal glycoprotein turnover (Akkermansia-associated pathways) that help sustain mucus layer thickness and signaling
  • Immunomodulatory metabolite synthesis (e.g., tryptophan metabolism such as indole and related pathways) influencing maternal-fetal immune calibration and infant seeding
  • Proteins/amino-acid fermentation to avoid excessive endotoxin and inflammatory byproducts; reduction in pathobiont-favoring proteolytic metabolism


Diversity note

During pregnancy, the maternal gut microbiome often undergoes a distinct shift in both composition and function, and these changes are frequently reflected in microbial diversity. In many health-associated pregnancies, diversity is maintained or only modestly altered, while the community’s metabolic capacity tends to be geared toward fermenting dietary fibers. This supports production of beneficial microbial metabolites—especially short-chain fatty acids (SCFAs)—which are closely tied to intestinal barrier integrity and a well-regulated immune tone.

In contrast, certain maternal exposures and behaviors are commonly associated with reduced gut microbial diversity and less efficient SCFA-generating activity. Diet patterns low in fiber, inadequate overall nutrition quality, and repeated antibiotic use can decrease the richness and evenness of the microbial ecosystem, disrupting the balance between beneficial fermenters and other taxa. The functional fallout is often a less favorable metabolite profile, which may weaken gut barrier maintenance and promote a more inflammatory signaling environment—conditions that can indirectly influence the microbial cues available to the developing infant.

Gut–vagina ecosystem disruption during pregnancy can also correlate with diversity changes in the gut. When dysbiosis occurs concurrently across these body sites, inflammatory mediators and altered immune pathways may be more pronounced, and this can coincide with lower microbial stability in the maternal gut. Over time, these diversity- and function-related shifts may shape early-life microbial colonization trajectories, affecting how the infant’s immune system calibrates to harmless antigens and how prone it is to inflammatory dysregulation later on.


Test Your Gut Microbiome Start Your Gut Microbiome Subscription

Why generic solutions fail

  • Issue with generic solutions

    Generic “one-size-fits-all” microbiome solutions usually fail in pregnancy because the maternal gut ecosystem is highly dynamic and context-dependent. Hormonal shifts, changes in gut motility, immune modulation, and altered substrate availability during gestation create a moving target; two people can have very different baseline microbial communities and different metabolic outputs even if they show similar symptoms. Interventions that ignore this functional context (for example, focusing only on increasing microbial counts rather than restoring fiber fermentation and short-chain fatty acid—SCFA—production) may miss the key mechanisms that support intestinal barrier integrity and balanced immune signaling, which are central to downstream infant immune training.

    They also often fail because pregnancy behaviors and exposures that shape the microbiome are not standardized. Fiber intake quality, gestational weight gain, sleep and stress load, and antibiotic timing can strongly determine whether beneficial SCFA-generating functions are sustained. If someone receives a generic probiotic or supplement without addressing upstream drivers like low dietary fiber or recent repeated antibiotics, the ecosystem may not have the substrates or ecological stability needed for beneficial taxa to persist or for metabolites to shift in a health-associated direction. As a result, improvements can be inconsistent, transient, or not aligned with the metabolite patterns most likely to matter for infant colonization.

    Finally, many generic approaches overlook the gut–vagina ecosystem interplay. Maternal dysbiosis can coincide across compartments via shared inflammatory mediators and immune signaling, meaning that correcting only one site without considering the broader maternal microbial network may not meaningfully lower the baseline inflammatory tone that influences early-life seeding. Without tailoring to the individual pattern of gastrointestinal and (when present) genital ecosystem disruption, interventions may have limited impact on the timing and trajectory of infant microbial establishment—where immune tolerance and long-term wellness trajectories begin to be set.

  • Common mistakes

    • Focusing on “more probiotics/microbes” (taxa counts) instead of restoring SCFA-generating function (e.g., fiber fermentation → acetate/propionate/butyrate) that supports barrier integrity and balanced immune signaling.
    • Using one-size-fits-all fiber recommendations without tailoring to baseline diet, tolerance (GI symptoms), or pregnancy-specific constraints—leading to insufficient substrate for beneficial fermentative taxa.
    • Ignoring prior and ongoing antibiotic exposure timing, which can permanently (or semi-permanently) alter ecosystem stability and reduce SCFA-generating capacity if not accounted for.
    • Not accounting for the dynamic, context-dependent nature of pregnancy (hormones, gut motility, immune modulation, gestational changes in metabolism), resulting in interventions that don’t match the gestation “moving target.”
    • Failing to assess individual baseline microbial diversity and metabolic output; assuming similar symptoms imply similar gut function, even when functional profiles (not just composition) differ.
    • Overlooking the upstream behavioral drivers (sleep/stress, dietary pattern quality, gestational weight gain, bowel habits) that determine whether beneficial metabolite pathways can persist.
    • Correcting only the maternal gut without considering gut–vagina ecosystem crosstalk (shared inflammatory mediators/immune signaling), so baseline inflammatory tone influencing infant seeding may not improve.
    • Applying interventions without continuity or ecological stabilization (e.g., short courses) despite pregnancy requiring sustained substrate availability for durable functional shifts—making benefits transient or inconsistent.

What to do

  • General support strategies

    Pregnancy naturally reshapes the maternal gut microbiome through hormonal shifts, changes in metabolism, altered gut motility, and immune modulation. Supporting a resilient maternal gut ecosystem during this window can help maintain intestinal barrier integrity and support balanced immune signaling. A key mechanism is the production of microbial metabolites—especially short-chain fatty acids (SCFAs)—which help regulate inflammation and strengthen gut barrier function. Because the maternal microbiome can influence the microbial “seed” an infant receives during pregnancy and at birth, optimizing maternal gut health may also support healthier early-life colonization and immune maturation.

    Diet and lifestyle are central levers for encouraging beneficial microbial diversity and function. Emphasizing a fiber-rich, plant-forward diet (including a variety of vegetables, legumes, whole grains, and other minimally processed foods) provides the substrates gut microbes use to generate SCFAs and other health-promoting compounds. Metabolic health also matters: stable blood sugar patterns, appropriate gestational weight gain, and regular sleep can indirectly support a more favorable microbial profile. Minimizing unnecessary antibiotic exposure when clinically possible, and using antibiotics only when prescribed, may help preserve microbial diversity and metabolite-producing capacity.

    Because gut and vaginal ecosystems are interconnected through shared immune and microbial influences, supporting overall microbiome balance may also help reduce the likelihood of recurrent disruptions. Addressing constipation, diarrhea, bloating, and other gastrointestinal symptoms early—along with managing stress—can support gut function and microbial stability. For many families, a consistent routine that combines adequate fiber intake, stress-aware habits, and judicious use of medications provides a practical foundation for promoting maternal microbial resilience and supporting infant immune development over the long term.

  • Lifestyle recommendations

    • Prioritize a high-fiber, plant-forward diet during pregnancy (e.g., legumes, whole grains, fruits, vegetables) to support beneficial gut microbes and short-chain fatty acid production.
    • Aim for stable, healthy gestational weight gain through balanced nutrition and appropriate activity, since metabolic shifts can affect the gut microbiome.
    • Limit unnecessary antibiotic use and use antibiotics only when medically indicated; discuss with your clinician any timing or need for probiotic/supportive strategies.
    • Manage stress and support good sleep (e.g., regular routines, relaxation practices, and seeking help for anxiety/insomnia), since stress hormones can alter gut microbial composition and immune signaling.
    • Stay physically active as recommended by your pregnancy care provider (e.g., walking), because gut motility changes during pregnancy can influence microbial balance.
    • Avoid smoking and minimize alcohol exposure (and avoid vaping where possible), as these can disrupt maternal and infant microbial ecosystems.
    • Support gastrointestinal and (if relevant) vaginal health by addressing persistent symptoms early with your clinician; avoid unnecessary douching or overuse of antimicrobial products.

  • Nutrition recommendations

    • Prioritize a high-fiber, whole-food diet (aim for a variety of vegetables, legumes, whole grains, nuts, seeds, and fruits) to support maternal gut microbial diversity and beneficial short-chain fatty acid production.
    • Include regular prebiotic-rich foods—such as onions, garlic, leeks, asparagus, oats, bananas/plantains, and legumes—to feed beneficial microbes during pregnancy.
    • Eat fiber + fermented foods consistently (e.g., yogurt with live cultures, kefir, fermented vegetables/kimchi/sauerkraut if tolerated) to support a healthier gut ecosystem and microbial metabolites.
    • Choose diverse, minimally processed carbohydrate sources (whole grains, beans, potatoes, fruit) to promote stable microbial fermentation and reduce reliance on high-sugar/refined foods that can shift the microbiome toward less favorable profiles.
    • Ensure adequate omega-3 intake (fatty fish like salmon/sardines, or algae-based DHA/EPA if preferred) to support anti-inflammatory immune signaling and overall metabolic health during pregnancy.
    • Support gut health with sufficient protein and micronutrients (iron, zinc, magnesium, folate, vitamin D where needed) from food first—especially from legumes, eggs/dairy, lean meats, and fortified alternatives—to help maintain barrier function and immune readiness.
    • If antibiotics are required, discuss timing and supportive nutrition with your clinician; during and after courses, focus on fiber + fermented foods to help re-establish beneficial microbial communities (avoid self-medicating probiotics without medical guidance).

  • Supplement considerations

    During pregnancy, the maternal gut microbiome is highly responsive to hormones, immune signaling, and metabolic changes, which means that supplement choices should ideally support microbial diversity, intestinal barrier integrity, and beneficial metabolite production (particularly short-chain fatty acids). Nutrients that feed “good” microbes, such as fermentable fibers and prebiotic substrates, may help strengthen gut function and lower inflammatory tone by promoting SCFA generation. Because gut motility and immune activity shift across trimesters, supplement timing and tolerability also matter—some women may be more sensitive to gas or bloating when increasing fermentable intake, so gradual titration is often preferred.

    Probiotic supplementation may also be considered for selected individuals, especially when there is evidence of dysbiosis associated with antibiotic exposure, recurrent gastrointestinal symptoms, or disruptions in gut and vaginal microbial balance. When choosing a probiotic, the strain matters more than the brand: benefits are generally strain- and dose-specific, and products with well-characterized clinical strains (and appropriate storage/stability) are more likely to be effective. In the context of maternal–infant health, probiotics may influence immune calibration indirectly by supporting barrier function and shaping microbial metabolites that affect immune signaling. However, supplementation should be tailored to the person’s history—particularly antibiotic timing, current GI symptoms, and whether there are pregnancy-related risks that require clinician oversight.

    Finally, because micronutrient status (e.g., vitamin D, iron, magnesium, and omega-3 fatty acids) and dietary patterns can influence gut ecology, supplements should complement—not replace—nutrient-dense eating that supports microbial resilience. Some nutrients can also affect microbiome composition (for example, changes in bile acids and inflammation pathways), which is why it’s important to avoid unnecessary or overlapping supplements unless there’s a clear indication. Overall, the most prudent approach is to select evidence-aligned prebiotics/probiotics and address key deficiencies with the guidance of a healthcare professional, aiming to foster a stable maternal gut environment that supports healthy early-life colonization and immune development in the infant.

  • Retesting / monitoring note

    Because maternal gut and immune signaling change across pregnancy, retesting is most informative when it captures key transition points rather than relying on a single timepoint. A baseline sample early in pregnancy (or preconception if available) can help characterize starting microbial diversity and metabolite potential, while a follow-up sample in the late second to third trimester can reflect pregnancy-associated shifts in hormones, gut motility, and immune modulation. If major perturbations occur—such as antibiotic treatment, hospitalization, significant changes in diet or fiber intake, or clinically relevant gastrointestinal symptoms—an additional retest after recovery can clarify whether the maternal microbiome is returning toward a more typical, metabolite-supporting state.

    Retesting should also be guided by the infant-focused reason for testing: supporting favorable early-life colonization and immune training. In practice, many programs align maternal retesting with infant milestones (for example, shortly around delivery or within the first weeks postpartum) to assess whether maternal microbial patterns and gut barrier–related functions may be consistent with the infant’s early exposures. When the clinical goal is to understand gut-vaginal ecosystem overlap—particularly in cases of recurrent vaginal symptoms, abnormal discharge, or GI disturbances—paired or coordinated sampling may be considered, since disruptions in one ecosystem can coincide with changes in the other and may influence colonization routes.

    Finally, to ensure retesting results are actionable, timing relative to interventions matters. Samples are generally most interpretable after avoiding antibiotics when possible (and following clinician guidance), maintaining dietary stability for at least several days prior to collection, and accounting for short-term confounders like acute illness, significant travel-related routine changes, or major medication adjustments. Using consistent collection methods and lab pipelines across retests can improve comparability, helping interpret whether observed shifts reflect normal pregnancy dynamics, recovery after exposures, or meaningful trends tied to long-term gut and immune health for both mother and infant.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing during pregnancy can help clarify how the maternal ecosystem is shifting in response to hormones, metabolism, gut motility, and immune signaling—factors that directly influence intestinal barrier integrity and the balance of inflammatory cues. By examining which microbes are present and, indirectly, what they may be doing (including the production of key metabolites like short-chain fatty acids), testing can reveal patterns associated with stronger or weaker gut barrier function. This matters because a healthier maternal gut ecology supports more regulated immune development, which can create a more favorable “starting environment” for the infant both during birth and in early life.

    Because maternal behaviors and exposures meaningfully shape microbial diversity and function, microbiome testing can also help identify likely drivers of disruption—such as low-fiber diet patterns, repeated antibiotic use, metabolic stress, or chronic sleep and stress. When these factors reduce beneficial microbes and alter metabolite output, they may be linked to gastrointestinal symptoms during pregnancy and broader ecosystem changes. Understanding what’s happening microbiologically can guide targeted conversations around diet quality, fiber intake, timing and necessity of antibiotics, and other lifestyle factors that support microbial resilience.

    Testing is also valuable for anticipating how maternal microbial patterns may relate to infant colonization and immune calibration. The early-life microbiome is closely tied to immune tolerance and inflammatory response development, and research suggests that specific early microbial trajectories can influence later risks such as allergic disease, certain inflammatory conditions, and metabolic health. In this way, gut microbiome testing can provide actionable insight into maternal-to-infant microbial transfer, helping clinicians and families make evidence-informed decisions that support long-term infant wellness.

  • How InnerBuddies helps

    InnerBuddies can help provide clarity on how pregnancy is reshaping a mother’s gut microbiome—an upstream factor that influences intestinal barrier integrity, immune signaling, and the metabolic environment that supports fetal and early-infant development. By profiling the maternal microbial ecosystem, the test can reveal shifts in community composition that often track with hormonal and metabolic changes during gestation. It also helps illuminate whether microbial patterns associated with beneficial metabolite production (including short-chain fatty acids that support gut barrier function and help regulate inflammation) are trending in a favorable direction or showing signs of disruption.

    Because maternal behaviors and exposures strongly affect microbial resilience, InnerBuddies can also act as a practical “signal” for likely drivers behind common pregnancy-related gut and ecosystem changes. For example, low fiber intake, repeated antibiotic use, metabolic stress, and chronic sleep or stress patterns can reduce microbial diversity and alter functional outputs. Understanding the microbiome changes that accompany these factors may help clinicians and families connect the dots between what’s happening biologically and what’s been experienced clinically—such as bloating, constipation, diarrhea, or susceptibility to vaginal ecosystem disturbances—so that supportive adjustments can be discussed with greater precision.

    Finally, the test can support longer-term infant wellness by helping anticipate how maternal microbial trajectories may relate to early-life colonization and immune maturation. The infant’s initial microbiome is influenced by maternal microbial transfer during pregnancy and birth, and certain early microbial patterns have been linked in research to later risks such as allergic disease, inflammatory conditions, and metabolic outcomes. By identifying maternal gut patterns that may be more supportive (or less so) of immune calibration, InnerBuddies can provide actionable, evidence-informed insight to guide nutrition and lifestyle conversations aimed at improving the “starting environment” for the infant.

Medical Evidence

  • Scientific evidence level

    2 [weak; emerging but inconsistent—strong biology and repeated associations, but limited causal and clinical-utility evidence]

  • Clinical relevance note

    Current clinical relevance is limited. Although maternal microbiome signals are an active research area and some studies report statistically significant associations with infant outcomes, the reproducibility problems and methodological variability (timing of stool collection, DNA extraction and sequencing batch effects, confounder control such as diet, BMI, antibiotics, socioeconomic factors, mode of delivery, and ethnicity) substantially reduce confidence in any single taxon/metric as a reliable clinical biomarker. Additionally, stool microbiome does not necessarily reflect mucosal immune-relevant communities, and sampling at one or a few timepoints may miss dynamic gestational changes.

    From a practice standpoint, there is no widely validated microbiome-based test for maternal risk prediction in routine obstetric care, and there is insufficient evidence that microbiome-targeted interventions during pregnancy reliably improve infant health outcomes in a clinically meaningful, mechanism-linked way. The most defensible near-term use is hypothesis generation and stratification for research (e.g., identifying subgroups or pathways), rather than clinical decision-making. Larger, well-standardized prospective cohorts with repeated sampling, rigorous external validation of predictive models, and adequately powered RCTs that incorporate microbiome endpoints and hard clinical outcomes are still needed before clinical utility can be considered high.

Title Journal Year Link
Maternal microbial transmission to the infant gut microbiome and its effect on infant immune development Cell Host & Microbe 2018 View →
The neonatal microbiome: development and implications for health and disease Nature Reviews Immunology 2017 View →
Maternal microbiome and infant gut microbiota in the first 6 months of life: a prospective cohort study Gut 2015 View →
The infant gut microbiome and its interaction with the environment and immune system Science 2012 View →
Maternal gut microbiome and risk of childhood obesity Nature Communications 2012 View →

Frequently Asked Questions

    ¿Qué es el microbioma intestinal materno y por qué es importante para mi bebé?
    Es la comunidad de microorganismos en tus intestinos; durante el embarazo puede influir en la integridad de la barrera intestinal y en las señales inmunitarias, ayudando al desarrollo del intestino y del sistema inmunitario de tu bebé. Es información general, no un diagnóstico.
    ¿Cómo puede la dieta influir en el microbioma intestinal durante el embarazo?
    Una dieta rica en fibra apoya microbios beneficiosos y la producción de SCFA; poca fibra o exposición repetida a antibióticos puede reducir la diversidad.
    ¿Los antibióticos durante el embarazo afectan el microbioma intestinal de mi bebé?
    Los antibióticos pueden modificar el microbioma materno y potencialmente influir en la transferencia de microbios al bebé; consulta la necesidad con tu médico.
    ¿Qué alimentos favorecen un microbioma intestinal saludable durante el embarazo?
    Alimentos ricos en fibra como frutas, verduras, granos integrales y legumbres; a veces alimentos fermentados; en general, una dieta equilibrada. Las necesidades individuales varían.
    ¿Un desequilibrio del microbioma de la madre puede aumentar el riesgo de alergias en mi bebé?
    Algunos estudios muestran asociaciones con el desarrollo inmunitario y riesgos futuros, pero los resultados varían; no es un resultado garantizado.
    ¿Cómo afecta el modo de parto la colonización intestinal del bebé?
    La vía de parto cambia la exposición inicial a microbios; parto vaginal frente a cesárea conduce a patrones de colonización temprana diferentes.
    ¿Qué es la prueba de microbioma durante el embarazo y qué puede revelar?
    Analiza patrones del microbioma y el potencial metabólico (como SCFA); no es un diagnóstico y debe ser interpretado por un profesional.
    ¿Debería hacerme una prueba de microbioma durante el embarazo?
    La prueba puede proporcionar información sobre cambios en el ecosistema materno y posibles factores de perturbación; no es necesaria para todos; hable con su médico.
    ¿Qué son los ácidos grasos de cadena corta y por qué son importantes?
    SCFA (acetato, propionato, butirato) apoyan la integridad de la barrera intestinal y regulan la señal inmunitaria; se producen por la fermentación de las fibras.
    ¿Cómo influyen el estrés y el sueño en mi intestino durante el embarazo?
    El estrés y la falta de sueño pueden afectar la motilidad intestinal y las respuestas inmunitarias, cambiando potencialmente los patrones del microbioma; se recomienda dormir bien y manejar el estrés.
    ¿Qué síntomas deberían hacer que hable con un profesional de la salud sobre mi intestino durante el embarazo?
    aumento de la hinchazón, estreñimiento o diarrea persistentes, dolor abdominal, secreciones vaginales inusuales o fatiga con cambios de peso deben consultarse.
    ¿Puede el microbioma materno influir en la salud futura de mi hijo?
    Existen asociaciones con resultados inmunitarios, inflamatorios y metabólicos; no son determinantes.
    ¿Existen bacterias beneficiosas específicas que debiera buscar en una prueba?
    Los resultados muestran la abundancia relativa de grupos beneficiosos; la interpretación debe hacerla un profesional. Nombres como Faecalibacterium o Bifidobacterium pueden aparecer.
    ¿Cómo puedo apoyar la barrera intestinal durante el embarazo?
    Prioriza alimentos ricos en fibra, una buena hidratación y evita antibióticos innecesarios; consulta con tu médico si tomas medicamentos.
    ¿Qué nivel de evidencia tienen estas afirmaciones?
    La investigación está en crecimiento; muchos hallazgos provienen de estudios observacionales y varían por población y método. Las pruebas no predicen con certeza.
    ¿En qué consiste la prueba y cómo se recogen las muestras?
    La mayoría de las pruebas usan muestras de heces para perfilar los microbios y deducir funciones; sigue las instrucciones del proveedor para la recolección y el momento.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -